Encorafenib, binimetinib and cetuximab in BRAF V600E-mutated advanced pancreatic adenocarcinoma

Autor: Zaanan, A., Dabout, V., Garinet, S., Giraud, D., Perkins, G., Taieb, J., Gallois, C.
Zdroj: In ESMO Open November 2024 9(11)
Databáze: ScienceDirect